Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

ClinicalTrials.gov ID: NCT03078686

Public ClinicalTrials.gov record NCT03078686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Biocellular Regenerative Therapy in Treating Scaring Alopecias and Alopecia Areata: Use of High Density Platelet-Rich Plasma Concentrates and Cell-Enriched Emulsified Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF)

Study identification

NCT ID
NCT03078686
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Regeneris Medical
Other
Enrollment
60 participants

Conditions and interventions

Interventions

  • tSVF by lipoaspiration Procedure
  • PRP Concentration Procedure
  • Emulsification tSVF Procedure
  • cSVF isolation and concentration Procedure
  • cSVF in Normal Saline IV Procedure

Procedure

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2017
Primary completion
Jan 21, 2025
Completion
Jun 21, 2025
Last update posted
Apr 15, 2020

2017 – 2025

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
Kenneth Williams, DO Irvine California 92618 Recruiting
Regeneris Medical North Attleboro Massachusetts 02760 Recruiting
Regenevita LLC Stevensville Montana 59870 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03078686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03078686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →